Free Trial

Elekta AB (publ) (OTCMKTS:EKTAY) Stock Price Crosses Below 50 Day Moving Average - Here's Why

Elekta AB (publ) logo with Medical background
Remove Ads

Elekta AB (publ) (OTCMKTS:EKTAY - Get Free Report) shares crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $5.76 and traded as low as $5.56. Elekta AB (publ) shares last traded at $5.59, with a volume of 2,214 shares changing hands.

Analysts Set New Price Targets

Separately, Sanford C. Bernstein upgraded shares of Elekta AB (publ) from a "strong sell" rating to a "hold" rating in a report on Wednesday, January 29th.

View Our Latest Stock Analysis on EKTAY

Elekta AB (publ) Price Performance

The company has a current ratio of 1.05, a quick ratio of 0.81 and a debt-to-equity ratio of 0.60. The business's fifty day moving average is $5.76 and its 200 day moving average is $5.95. The company has a market cap of $2.12 billion, a P/E ratio of 22.14 and a beta of 1.25.

Elekta AB (publ) (OTCMKTS:EKTAY - Get Free Report) last posted its quarterly earnings results on Friday, February 21st. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.01). Elekta AB (publ) had a return on equity of 11.07% and a net margin of 5.65%. The firm had revenue of $416.86 million for the quarter, compared to the consensus estimate of $435.89 million. As a group, sell-side analysts anticipate that Elekta AB will post 0.36 EPS for the current year.

Remove Ads

Elekta AB (publ) Cuts Dividend

The firm also recently disclosed a dividend, which will be paid on Thursday, March 27th. Investors of record on Friday, March 7th will be paid a $0.1072 dividend. The ex-dividend date of this dividend is Friday, March 7th. Elekta AB (publ)'s dividend payout ratio is 44.00%.

Elekta AB (publ) Company Profile

(Get Free Report)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.

Read More

Should You Invest $1,000 in Elekta AB (publ) Right Now?

Before you consider Elekta AB (publ), you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elekta AB (publ) wasn't on the list.

While Elekta AB (publ) currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads